Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd. (ACBM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
acbm · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Acro Biomedical Co., Ltd. (ACBM) measures how much investors pay for each dollar of the company's trailing earnings. ACBM's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2014 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Acro Biomedical Co., Ltd.You ACBM | $2M | N/A | — | -$0.00 |
 Amarantus BioScience Holdings, Inc. AMBS | $0M | N/A | — | -$0.01 |
 Baseline Productions, Inc. BSSP | $0M | N/A | — | -$0.01 |
 Health Discovery Corporation HDVY | $0M | N/A | — | -$0.00 |
 iBX Group, Inc. IBXG | $0M | N/A | — | — |
 Interactive Health Network IGRW | $0M | 32.58x | — | $0.00 |
 Itoco Inc. ITMC | $0M | N/A | — | -$0.01 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.00 | — | |
2024-12-31 FY2024 | — | $-0.00 | — | |
2023-12-31 FY2023 | — | $-0.15 | — | |
2022-12-31 FY2022 | — | $-0.26 | — | |
2021-12-31 FY2021 | — | $-0.14 | — | |
2020-12-31 FY2020 | — | $-0.00 | — | |
2019-12-31 FY2019 | — | $-0.01 | — | |
2018-09-30 FY2018 | 441.79x | $0.01 | — | |
2017-09-30 FY2017 | — | $-0.00 | — | |
2016-09-30 FY2016 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Acro Biomedical Co., Ltd. (ACBM) measures how much investors pay for each dollar of the company's trailing earnings. ACBM's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of -$0.00.
Frequently asked questions
ACBM pe ratio · 6 questionsACBM's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.03 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via ACBM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Acro Biomedical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09